AC Immune (ACIU) Total Non-Current Liabilities (2014 - 2026)
AC Immune's Total Non-Current Liabilities came in at $18.97 million for the quarter ended Jun 30, 2026, down 4.9% from $19.94 million a year earlier but up 8.9% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
As of Dec 31, 2025, AC Immune's Total Non-Current Liabilities was $17.7 million, down 12.6% from the prior year.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of 12.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, Total Non-Current Liabilities was $20.24 million in the year ended Dec 31, 2024 (+111.5%), $9.57 million in the year ended Dec 31, 2023 (+67.0%), $5.73 million in the year ended Dec 31, 2022 (-44.5%) and $10.33 million in the year ended Dec 31, 2021 (+4.8%).
- The five-year range for quarterly Total Non-Current Liabilities is $1.97 million (the quarter ended Sep 30, 2022) to $20.32 million (the quarter ended Dec 31, 2024).
- Year-over-year, Total Non-Current Liabilities has declined for four consecutive quarters, with growth averaging 42.9% over the last eight quarters.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in the quarter ended Sep 30, 2023 (growth of 222.4%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 81.8%).
- Business Quant data shows ACIU's Total Non-Current Liabilities at $17.42 million (quarter ended Mar 31, 2026), $18.36 million (quarter ended Dec 31, 2025) and $13.6 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | AC Immune | 249.36 Mn | -189.04 Mn | - | 18.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.56 Mn |
| Mar 31, 2026 | 17.05 Mn |
| Dec 31, 2025 | 18.53 Mn |
| Sep 30, 2025 | 13.64 Mn |
| Jun 30, 2025 | 20.69 Mn |
| Mar 31, 2025 | 19.34 Mn |
| Dec 31, 2024 | 19.71 Mn |
| Sep 30, 2024 | 15.58 Mn |
| Jun 30, 2024 | 15.11 Mn |
| Mar 31, 2024 | 9.41 Mn |
| Dec 31, 2023 | 10.19 Mn |
| Sep 30, 2023 | 6.13 Mn |
| Jun 30, 2023 | 6.39 Mn |
| Mar 31, 2023 | 5.98 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 10.27 Mn |
| Dec 31, 2021 | 10.33 Mn |
| Sep 30, 2021 | 10.65 Mn |
API Access
AC Immune Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();